# ImmunoPET With an Anti-CD8 Imaging Agent

> **NCT04029181** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 47 (actual)

## Conditions studied

- Metastatic Cancer
- Unresectable Malignant Neoplasm

## Interventions

- **OTHER:** Anti-CD8 PET imaging agent

## Key facts

- **NCT ID:** NCT04029181
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-14
- **Primary completion:** 2022-12-28
- **Final completion:** 2024-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04029181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04029181, "ImmunoPET With an Anti-CD8 Imaging Agent". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04029181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*